Trial intelligence / Profile preview

PEG 3350, Bisacodyl and Prucalopride on Colonic Motility in Healthy Subjects

NCT03279341Phase 4Completed

Sponsor
UZ Leuven
Start
Dec 2012
Primary completion
Mar 2016
Modality
Injectable Hydrogels, Implantable Hydrogels, Biodegradable Polymers
Countries
1
01

Overview

A Phase 4 trial of polyethylene glycol 3350, bisacodyl, prucalopride in chronic constipation, sponsored by UZ Leuven. Started Dec 2012; status: completed.

02

Drugs

polyethylene glycol 3350bisacodylprucalopride
03

Conditions

chronic constipation

Beyond the preview

Go deeper on NCT03279341.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03279341.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call